Jeffrey W. Albers Kymera Therapeutics, Inc. (KYMR) insider trading activity

Jeffrey W. Albers is of Kymera Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KYMR, which is worth approximately $0. The most recent transaction as insider was on Feb 21, 2024, when has been sold 4,385 shares (Common Stock) at a price of $39.05 per share, resulting in proceeds of $171,234. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

Jeffrey W. Albers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 21 2024	SELL Open market or private sale	$171,234 $39.05 p/Share	4,385 Reduced 100.0%	0 Common Stock
Feb 21 2024	BUY Exercise of conversion of derivative security	$45,340 $10.34 p/Share	4,385 Added 50.0%	4,385 Common Stock
Feb 20 2024	SELL Open market or private sale	$24,028 $39.07 p/Share	615 Reduced 100.0%	0 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	$6,359 $10.34 p/Share	615 Added 50.0%	615 Common Stock
Jan 23 2024	SELL Open market or private sale	$300,500 $30.05 p/Share	10,000 Reduced 100.0%	0 Common Stock
Jan 23 2024	BUY Exercise of conversion of derivative security	$103,400 $10.34 p/Share	10,000 Added 50.0%	10,000 Common Stock

Also insider at

BPMC

Blueprint Medicines Corp Healthcare

MGTA

Magenta Therapeutics, Inc. Healthcare

Director

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

JWA

Jeffrey W. Albers

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Value

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR

Account